Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
All News about Halozyme Therapeutics, Inc. - Common Stock
Via Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
Via Benzinga
Via Benzinga

Assessing Halozyme Therapeutics: Insights From 9 Financial Analysts
February 20, 2025
Via Benzinga

Demystifying Halozyme Therapeutics: Insights From 8 Analyst Reviews
February 04, 2025
Via Benzinga
Via Stocktwits
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
April 11, 2025
Via Benzinga
Exposures
Product Safety
Peering Into Halozyme Therapeutics's Recent Short Interest
April 11, 2025
Via Benzinga
Via Chartmill






Earnings Scheduled For February 18, 2025
February 18, 2025
Via Benzinga


Via Chartmill


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.